- Services
- Solutions
- Expertise
- About Us
- Resources
- Contact Us
New Haven, CT – NorthEast BioLab, a boutique bioanalytical services contract research organization (CRO), today announced expansion of their laboratory facilities.
“We are committed to investing in technology and infrastructure that will strengthen our value proposition. NorthEast BioLab is expanding its facilities to efficiency fulfill our rising service demand”, commented Dr. Vipin Agarwal, President & CEO of NorthEast BioLab. These additions expand upon the Company’s established facilities in New Haven, CT.
NorthEast BioLab is scaling its operations to ensure continued customer satisfaction. The new facilities address the company’s strong growth. Simultaneously, the team aims to maintain their high-quality service as well as regulatory and quality control standards. It seems NorthEast BioLab’s now better equipped to provide uninterrupted and faster turnaround, helping in turn accelerate development and research efforts of their clients.
“Our clients’ support and continued partnership is critical for our Company. We thank them and look forward to new growth opportunities in the near future. Moreover, we invite all current and potential clients to learn more about us. Finally, we welcome the opportunity to discuss any questions or concerns”, said Abhay Pandey, VP of Business and Corporate Development.
About NorthEast BioLab
NorthEast BioLab LLC, based in New Haven, CT, is an independent bioanalytical service provider with over 15 years of experience performing small and large molecule bioanalytical services for clinical, preclinical, and drug discovery studies. The company has an excellent track record of advancing PK, BA/BE, TK, Immunogenicity, Biomarker, and custom assays. Services include method development and validation using LC-MS, ELISA, MSD, Luminex, Western Blot, and qPCR, among other technologies. NorthEast BioLab is GLP/GCLP compliant, FDA audited, and DEA and CT State Schedule II-IV approved. Clients span the top ten Pharmaceutical companies and emerging Connecticut and Cambridge, MA biotech. The NorthEast BioLab team has successfully supported numerous preclinical and clinical studies and continues to partner with several leading research and academic institutions across the nation.
For more information about the investment program, please contact:
Abhay Pandey, MBA
VP, Business Development
NorthEast BioLab
925 Sherman Avenue
Hamden, CT 06514
T: (203) 361 3780
E: abhay.pandey@nebiolab.com
